Diatech Pharmacogenetics is the Italian leader in the development, production, and commercialization of pharmacogenetics tests for cancer precision medicine. Founded in 1996, the company has achieved significant growth, holding over 70% of the Italian molecular diagnostic market and expanding rapidly worldwide. With more than 20,000 diagnostic tests performed, Diatech reinvests 20% of its revenues into R&D annually. The company offers a range of pharmacogenetics tests across various platforms, providing comprehensive solutions that include reagents, instruments, and support for diagnostic operators. Their latest products feature advanced technologies such as liquid biopsy cfDNA extraction kits and end-to-end NGS solutions, all developed under strict quality standards and regulatory compliance.
Something looks off?On-site & Remote